Holdings
Versant Venture Management, LLC
As of Sep 30, 2026, Versant Venture Management, LLC reported 5 positions worth US$100M. Largest: Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc. and Contineum Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 3.18M | US$37.9M | no change | Sep 30, 2026 |
| Century Therapeutics, Inc. | 12.2M | US$20.8M | no change | Sep 30, 2026 |
| Contineum Therapeutics, Inc. | 1.29M | US$17.3M | +750K | Sep 30, 2026 |
| Jade Biosciences, Inc. | 992K | US$13.9M | no change | Sep 30, 2026 |
| LENZ Therapeutics, Inc. | 2.66M | US$10.2M | no change | Sep 30, 2026 |